Synthetic and Natural Coumarins as Cytotoxic Agents
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
29-46
Author(s):
Irena Kostova
Novel Anticancer Targets and Drug Discovery in Post Genomic Age
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
53-63
Author(s):
Qianbin Li and Wenfang Xu
Novel Insights and Therapeutical Applications in the Field of Inhibitors of COX-2
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
3147-3161
Author(s):
W. Kiefer and G. Dannhardt
“Virostatics” as a Potential New Class of HIV Drugs
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
4103-4120
Author(s):
L. M. Kelly, J. Lisziewicz and F. Lori
Recent Advances in Chemical Genomics
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
3119-3145
Author(s):
F. Darvas, G. Dorman, P. Krajcsi, L. G. Puskas, Z. Kovari, Z. Lorincz and L. Urge
Phytoestrogens: Implications in Neurovascular Research
Journal:
Current Neurovascular Research
Volume:
1
Page:
455-464
Author(s):
Edwin D. Lephart, James P. Porter, Dawson W. Hedges, Trent D. Lund and Kenneth D.R. Setchell
Mammalian Target of Rapamycin (mTOR) Inhibitors as Anti-Cancer Agents
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
621-635
Author(s):
Ravi D. Rao, Jan C. Buckner and Jann N. Sarkaria
Wnt / β-Catenin Signaling Pathway as Novel Cancer Drug Targets
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
653-671
Author(s):
Hue H. Luu, Ruiwen Zhang, Rex C. Haydon, Elizabeth Rayburn, Quan Kang, Weike Si, Jong Kyung Park, Hui Wang, Ying Peng, Wei Jiang and Tong- Chuan He
Surface Antigens/Receptors for Targeted Cancer Treatment: The GnRH Receptor / Binding Site for Targeted Adenocarcinoma Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
673-687
Author(s):
R. Eaveri, A. Ben-Yehudah and H. Lorberboum-Galski
Bacteria and Bacterial Toxins as Therapeutic Agents for Solid Tumors
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
689-702
Author(s):
P. Michl and T. M. Gress